166 related articles for article (PubMed ID: 36338735)
21. Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
Tan Y; Feng LJ; Huang YH; Xue JW; Feng ZB; Long LL
BMC Cancer; 2024 Mar; 24(1):368. PubMed ID: 38519974
[TBL] [Abstract][Full Text] [Related]
22. Machine Learning-Based CT Radiomics Method for Identifying the Stage of Wilms Tumor in Children.
Ma XH; Shu L; Jia X; Zhou HC; Liu TT; Liang JW; Ding YS; He M; Shu Q
Front Pediatr; 2022; 10():873035. PubMed ID: 35676904
[TBL] [Abstract][Full Text] [Related]
23. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
24. Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients.
Shiri I; Sorouri M; Geramifar P; Nazari M; Abdollahi M; Salimi Y; Khosravi B; Askari D; Aghaghazvini L; Hajianfar G; Kasaeian A; Abdollahi H; Arabi H; Rahmim A; Radmard AR; Zaidi H
Comput Biol Med; 2021 May; 132():104304. PubMed ID: 33691201
[TBL] [Abstract][Full Text] [Related]
25. CT Characteristics of Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis.
Kim TH; Woo S; Yoon SH; Halpenny DF; Han S; Suh CH
AJR Am J Roentgenol; 2019 Nov; 213(5):1059-1072. PubMed ID: 31414902
[No Abstract] [Full Text] [Related]
26. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
27. PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features.
Huang W; Wang J; Wang H; Zhang Y; Zhao F; Li K; Su L; Kang F; Cao X
Front Pharmacol; 2022; 13():898529. PubMed ID: 35571081
[No Abstract] [Full Text] [Related]
28. Machine learning based on clinico-biological features integrated
Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
[TBL] [Abstract][Full Text] [Related]
29. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
30. Classification of Histological Types and Stages in Non-small Cell Lung Cancer Using Radiomic Features Based on CT Images.
Lin J; Yu Y; Zhang X; Wang Z; Li S
J Digit Imaging; 2023 Jun; 36(3):1029-1037. PubMed ID: 36828962
[TBL] [Abstract][Full Text] [Related]
31. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
32. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Ruan D; Fang J; Teng X
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
[TBL] [Abstract][Full Text] [Related]
33. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
34. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
Front Oncol; 2021; 11():719919. PubMed ID: 34660285
[TBL] [Abstract][Full Text] [Related]
35. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
36. Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.
Yi X; Liu Y; Zhou B; Xiang W; Deng A; Fu Y; Zhao Y; Ouyang Q; Liu Y; Sun Z; Zhang K; Li X; Zeng F; Zhou H; Chen BT
Biomed Pharmacother; 2021 Jan; 133():111013. PubMed ID: 33227705
[TBL] [Abstract][Full Text] [Related]
37. Machine learning for predicting accuracy of lung and liver tumor motion tracking using radiomic features.
Li G; Zhang X; Song X; Duan L; Wang G; Xiao Q; Li J; Liang L; Bai L; Bai S
Quant Imaging Med Surg; 2023 Mar; 13(3):1605-1618. PubMed ID: 36915317
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Feature Selection Methods and Machine Learning Classifiers for Predicting Chronic Obstructive Pulmonary Disease Using Texture-Based CT Lung Radiomic Features.
Makimoto K; Au R; Moslemi A; Hogg JC; Bourbeau J; Tan WC; Kirby M
Acad Radiol; 2023 May; 30(5):900-910. PubMed ID: 35965158
[TBL] [Abstract][Full Text] [Related]
40. Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
Mendoza DP; Stowell J; Muzikansky A; Shepard JO; Shaw AT; Digumarthy SR
Clin Lung Cancer; 2019 Sep; 20(5):339-349. PubMed ID: 31164317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
